Select your location to view local American Lung Association events and news near you.

There are roughly 225,000 new cases of lung cancer every year in the United States. Early diagnosis and treatment play a large role in improving outcomes. A recently developed nasal swab test could ...

ATLANTA, Georgia — A combination of gene-expression testing (BronchoGen, Allegro Diagnostics) and diagnostic bronchoscopy significantly improves accuracy in the diagnosis of lung cancer, compared with ...

SAN ANTONIO, Texas--(BUSINESS WIRE)--A new economic study found that adding CyPath® Lung, bioAffinity Technologies’ noninvasive test for detection of early-stage lung cancer, to the standard of care ...

An X-ray can help healthcare professionals find non-small cell lung cancer tumors and gain a deeper understanding of them. The healthcare team will also need other imaging and tests for a complete ...

The most common way to assess lung age is through a spirometry test. In this procedure, a person takes a deep breath and then ...

HAMPTON ROADS, Va. (WAVY) — Lung cancer is the leading cause of cancer deaths in America, and catching it early is vital. That’s exactly what a low-dose CT scan does, but only one-in-10 people at ...

Complications after invasive diagnostic procedures for lung abnormalities occurred twice as often in the real-world setting than in clinical trials that served as the basis for adoption of lung cancer ...

Investing.com -- Bioaffinity Technologies Inc (NASDAQ:BIAF) stock soared 79% in premarket trading Friday after the biotechnology company released three new case studies highlighting the effectiveness ...

Study by BAMC’s Michael Morris, M.D., and VA’s Sheila Habib, M.D., evaluated potential economic impact of CyPath® Lung for the early detection of lung cancer “Our study suggests the potential for a ...